New method provides valuable insights into the brain’s noradrenaline system

An international team of researchers has provided valuable insights into the brain’s noradrenaline (NA) system, which has been a longtime target for medications to treat attention-deficit/hyperactivity disorder, depression, and anxiety.

Assessing Tardive Dyskinesia Risk

Any patient on a dopamine receptor-blocking medication may develop tardive dyskinesia (TD), though most often the condition is associated with antipsychotic medications. “You would be

Read More »